nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2B6—Thiotepa—urinary bladder cancer	0.191	0.315	CbGbCtD
Fosphenytoin—ALB—Fluorouracil—urinary bladder cancer	0.0609	0.1	CbGbCtD
Fosphenytoin—CYP3A4—Thiotepa—urinary bladder cancer	0.0588	0.0969	CbGbCtD
Fosphenytoin—CYP2B6—Cisplatin—urinary bladder cancer	0.0528	0.087	CbGbCtD
Fosphenytoin—CYP2C8—Fluorouracil—urinary bladder cancer	0.0471	0.0776	CbGbCtD
Fosphenytoin—CYP2C8—Etoposide—urinary bladder cancer	0.0393	0.0648	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—urinary bladder cancer	0.0354	0.0583	CbGbCtD
Fosphenytoin—ALB—Methotrexate—urinary bladder cancer	0.0336	0.0554	CbGbCtD
Fosphenytoin—CYP2C9—Fluorouracil—urinary bladder cancer	0.0328	0.0541	CbGbCtD
Fosphenytoin—CYP2C9—Cisplatin—urinary bladder cancer	0.0279	0.046	CbGbCtD
Fosphenytoin—CYP3A4—Etoposide—urinary bladder cancer	0.0159	0.0263	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0109	0.0179	CbGbCtD
Fosphenytoin—Paraesthesia—Cisplatin—urinary bladder cancer	0.00022	0.000676	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00022	0.000676	CcSEcCtD
Fosphenytoin—Tachycardia—Etoposide—urinary bladder cancer	0.000219	0.000674	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000218	0.000672	CcSEcCtD
Fosphenytoin—Dyspnoea—Cisplatin—urinary bladder cancer	0.000218	0.000672	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000217	0.000667	CcSEcCtD
Fosphenytoin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000216	0.000666	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000216	0.000665	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000216	0.000664	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000215	0.000663	CcSEcCtD
Fosphenytoin—Anorexia—Etoposide—urinary bladder cancer	0.000214	0.000658	CcSEcCtD
Fosphenytoin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000214	0.000657	CcSEcCtD
Fosphenytoin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000213	0.000655	CcSEcCtD
Fosphenytoin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000213	0.000655	CcSEcCtD
Fosphenytoin—Bronchitis—Epirubicin—urinary bladder cancer	0.000213	0.000654	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—urinary bladder cancer	0.000212	0.000652	CcSEcCtD
Fosphenytoin—Hypotension—Etoposide—urinary bladder cancer	0.00021	0.000645	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—urinary bladder cancer	0.000209	0.000645	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000209	0.000642	CcSEcCtD
Fosphenytoin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000208	0.000639	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—urinary bladder cancer	0.000207	0.000637	CcSEcCtD
Fosphenytoin—Dysuria—Epirubicin—urinary bladder cancer	0.000207	0.000636	CcSEcCtD
Fosphenytoin—Dizziness—Thiotepa—urinary bladder cancer	0.000206	0.000635	CcSEcCtD
Fosphenytoin—Urticaria—Fluorouracil—urinary bladder cancer	0.000205	0.000631	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000205	0.00063	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—urinary bladder cancer	0.000205	0.000629	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—urinary bladder cancer	0.000205	0.000629	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—urinary bladder cancer	0.000205	0.000629	CcSEcCtD
Fosphenytoin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000204	0.000628	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—urinary bladder cancer	0.000202	0.000621	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000202	0.000621	CcSEcCtD
Fosphenytoin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000202	0.000621	CcSEcCtD
Fosphenytoin—Paraesthesia—Etoposide—urinary bladder cancer	0.000201	0.00062	CcSEcCtD
Fosphenytoin—Dyspnoea—Etoposide—urinary bladder cancer	0.0002	0.000615	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000199	0.000614	CcSEcCtD
Fosphenytoin—Somnolence—Etoposide—urinary bladder cancer	0.000199	0.000614	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—urinary bladder cancer	0.000199	0.000611	CcSEcCtD
Fosphenytoin—Vomiting—Thiotepa—urinary bladder cancer	0.000198	0.000611	CcSEcCtD
Fosphenytoin—Pneumonia—Epirubicin—urinary bladder cancer	0.000198	0.00061	CcSEcCtD
Fosphenytoin—Rash—Thiotepa—urinary bladder cancer	0.000197	0.000606	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—urinary bladder cancer	0.000197	0.000605	CcSEcCtD
Fosphenytoin—Dermatitis—Thiotepa—urinary bladder cancer	0.000197	0.000605	CcSEcCtD
Fosphenytoin—Headache—Thiotepa—urinary bladder cancer	0.000196	0.000602	CcSEcCtD
Fosphenytoin—Decreased appetite—Etoposide—urinary bladder cancer	0.000195	0.0006	CcSEcCtD
Fosphenytoin—Renal failure—Epirubicin—urinary bladder cancer	0.000194	0.000596	CcSEcCtD
Fosphenytoin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000193	0.000596	CcSEcCtD
Fosphenytoin—Constipation—Etoposide—urinary bladder cancer	0.000192	0.00059	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000192	0.00059	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—urinary bladder cancer	0.000191	0.000589	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—urinary bladder cancer	0.000189	0.000582	CcSEcCtD
Fosphenytoin—Asthenia—Gemcitabine—urinary bladder cancer	0.000188	0.00058	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000188	0.000578	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000187	0.000575	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—urinary bladder cancer	0.000186	0.000572	CcSEcCtD
Fosphenytoin—Pruritus—Gemcitabine—urinary bladder cancer	0.000186	0.000572	CcSEcCtD
Fosphenytoin—Nausea—Thiotepa—urinary bladder cancer	0.000185	0.000571	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—urinary bladder cancer	0.000185	0.000569	CcSEcCtD
Fosphenytoin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000185	0.000569	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000184	0.000568	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—urinary bladder cancer	0.000183	0.000565	CcSEcCtD
Fosphenytoin—Pruritus—Fluorouracil—urinary bladder cancer	0.000183	0.000562	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—urinary bladder cancer	0.00018	0.000554	CcSEcCtD
Fosphenytoin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00018	0.000553	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—urinary bladder cancer	0.000179	0.000552	CcSEcCtD
Fosphenytoin—Urticaria—Etoposide—urinary bladder cancer	0.000178	0.000548	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—urinary bladder cancer	0.000177	0.000546	CcSEcCtD
Fosphenytoin—Body temperature increased—Etoposide—urinary bladder cancer	0.000177	0.000546	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000177	0.000546	CcSEcCtD
Fosphenytoin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000177	0.000544	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—urinary bladder cancer	0.000176	0.000543	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000176	0.000542	CcSEcCtD
Fosphenytoin—Asthenia—Cisplatin—urinary bladder cancer	0.000176	0.000541	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000176	0.00054	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—urinary bladder cancer	0.000175	0.000538	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000172	0.000529	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000171	0.000527	CcSEcCtD
Fosphenytoin—Dizziness—Fluorouracil—urinary bladder cancer	0.000171	0.000526	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—urinary bladder cancer	0.00017	0.000522	CcSEcCtD
Fosphenytoin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000167	0.000515	CcSEcCtD
Fosphenytoin—Vomiting—Gemcitabine—urinary bladder cancer	0.000167	0.000514	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—urinary bladder cancer	0.000167	0.000513	CcSEcCtD
Fosphenytoin—Rash—Gemcitabine—urinary bladder cancer	0.000166	0.00051	CcSEcCtD
Fosphenytoin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000165	0.000509	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—urinary bladder cancer	0.000165	0.000508	CcSEcCtD
Fosphenytoin—Headache—Gemcitabine—urinary bladder cancer	0.000165	0.000506	CcSEcCtD
Fosphenytoin—Vomiting—Fluorouracil—urinary bladder cancer	0.000164	0.000505	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000164	0.000505	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000163	0.000501	CcSEcCtD
Fosphenytoin—Rash—Fluorouracil—urinary bladder cancer	0.000163	0.000501	CcSEcCtD
Fosphenytoin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000163	0.000501	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000162	0.0005	CcSEcCtD
Fosphenytoin—Headache—Fluorouracil—urinary bladder cancer	0.000162	0.000498	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000161	0.000496	CcSEcCtD
Fosphenytoin—Asthenia—Etoposide—urinary bladder cancer	0.000161	0.000495	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—urinary bladder cancer	0.000159	0.00049	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—urinary bladder cancer	0.000159	0.000489	CcSEcCtD
Fosphenytoin—Pruritus—Etoposide—urinary bladder cancer	0.000159	0.000488	CcSEcCtD
Fosphenytoin—Nausea—Gemcitabine—urinary bladder cancer	0.000156	0.00048	CcSEcCtD
Fosphenytoin—Vomiting—Cisplatin—urinary bladder cancer	0.000156	0.000479	CcSEcCtD
Fosphenytoin—Rash—Cisplatin—urinary bladder cancer	0.000154	0.000475	CcSEcCtD
Fosphenytoin—Dermatitis—Cisplatin—urinary bladder cancer	0.000154	0.000475	CcSEcCtD
Fosphenytoin—Diarrhoea—Etoposide—urinary bladder cancer	0.000153	0.000472	CcSEcCtD
Fosphenytoin—Nausea—Fluorouracil—urinary bladder cancer	0.000153	0.000472	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000153	0.00047	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000153	0.00047	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—urinary bladder cancer	0.000152	0.000468	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—urinary bladder cancer	0.000152	0.000467	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—urinary bladder cancer	0.000151	0.000465	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000151	0.000464	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—urinary bladder cancer	0.00015	0.00046	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—urinary bladder cancer	0.000149	0.000459	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—urinary bladder cancer	0.000148	0.000457	CcSEcCtD
Fosphenytoin—Dizziness—Etoposide—urinary bladder cancer	0.000148	0.000456	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000148	0.000456	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—urinary bladder cancer	0.000148	0.000455	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—urinary bladder cancer	0.000147	0.000453	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—urinary bladder cancer	0.000147	0.000452	CcSEcCtD
Fosphenytoin—Nausea—Cisplatin—urinary bladder cancer	0.000145	0.000447	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—urinary bladder cancer	0.000144	0.000442	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000143	0.00044	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—urinary bladder cancer	0.000143	0.000439	CcSEcCtD
Fosphenytoin—Vomiting—Etoposide—urinary bladder cancer	0.000143	0.000439	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—urinary bladder cancer	0.000142	0.000438	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—urinary bladder cancer	0.000142	0.000436	CcSEcCtD
Fosphenytoin—Rash—Etoposide—urinary bladder cancer	0.000141	0.000435	CcSEcCtD
Fosphenytoin—Dermatitis—Etoposide—urinary bladder cancer	0.000141	0.000435	CcSEcCtD
Fosphenytoin—Headache—Etoposide—urinary bladder cancer	0.00014	0.000432	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—urinary bladder cancer	0.00014	0.000432	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—urinary bladder cancer	0.00014	0.000431	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—urinary bladder cancer	0.00014	0.000431	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—urinary bladder cancer	0.00014	0.00043	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00014	0.00043	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—urinary bladder cancer	0.000139	0.000427	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—urinary bladder cancer	0.000138	0.000426	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—urinary bladder cancer	0.000138	0.000426	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—urinary bladder cancer	0.000138	0.000426	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—urinary bladder cancer	0.000138	0.000425	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—urinary bladder cancer	0.000138	0.000424	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—urinary bladder cancer	0.000138	0.000424	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000137	0.000422	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—urinary bladder cancer	0.000136	0.000419	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—urinary bladder cancer	0.000135	0.000417	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000135	0.000417	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—urinary bladder cancer	0.000134	0.000414	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000134	0.000413	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—urinary bladder cancer	0.000133	0.000411	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—urinary bladder cancer	0.000133	0.000411	CcSEcCtD
Fosphenytoin—Nausea—Etoposide—urinary bladder cancer	0.000133	0.00041	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—urinary bladder cancer	0.000133	0.000409	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000132	0.000407	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—urinary bladder cancer	0.000132	0.000405	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000132	0.000405	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—urinary bladder cancer	0.000131	0.000404	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—urinary bladder cancer	0.000131	0.000404	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—urinary bladder cancer	0.000131	0.000403	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00013	0.0004	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—urinary bladder cancer	0.00013	0.000399	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—urinary bladder cancer	0.000129	0.000396	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—urinary bladder cancer	0.000128	0.000395	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—urinary bladder cancer	0.000128	0.000394	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—urinary bladder cancer	0.000128	0.000394	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—urinary bladder cancer	0.000128	0.000393	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000128	0.000393	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—urinary bladder cancer	0.000127	0.00039	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—urinary bladder cancer	0.000126	0.000388	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000126	0.000387	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—urinary bladder cancer	0.000126	0.000386	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000125	0.000386	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—urinary bladder cancer	0.000125	0.000384	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—urinary bladder cancer	0.000124	0.000383	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—urinary bladder cancer	0.000124	0.000381	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—urinary bladder cancer	0.000123	0.00038	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000123	0.000379	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—urinary bladder cancer	0.000123	0.000379	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—urinary bladder cancer	0.000123	0.000378	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000122	0.000377	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000122	0.000374	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—urinary bladder cancer	0.000121	0.000374	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000121	0.000373	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—urinary bladder cancer	0.000121	0.000373	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000121	0.000371	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—urinary bladder cancer	0.00012	0.000369	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—urinary bladder cancer	0.00012	0.000369	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—urinary bladder cancer	0.00012	0.000369	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—urinary bladder cancer	0.000119	0.000368	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000119	0.000365	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000118	0.000364	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—urinary bladder cancer	0.000117	0.000362	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—urinary bladder cancer	0.000117	0.000361	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000117	0.000359	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000116	0.000358	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—urinary bladder cancer	0.000116	0.000356	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000115	0.000352	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—urinary bladder cancer	0.000114	0.000352	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000114	0.00035	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—urinary bladder cancer	0.000114	0.00035	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000114	0.000349	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000113	0.000347	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000112	0.000346	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000112	0.000345	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—urinary bladder cancer	0.000112	0.000344	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—urinary bladder cancer	0.000111	0.000341	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000111	0.000341	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000111	0.000341	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000109	0.000336	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—urinary bladder cancer	0.000109	0.000335	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—urinary bladder cancer	0.000107	0.000331	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—urinary bladder cancer	0.000107	0.000328	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000106	0.000327	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000106	0.000326	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—urinary bladder cancer	0.000105	0.000324	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000104	0.000321	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000104	0.000319	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000104	0.000319	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—urinary bladder cancer	0.000103	0.000318	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000102	0.000315	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000101	0.000311	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—urinary bladder cancer	9.99e-05	0.000307	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—urinary bladder cancer	9.95e-05	0.000306	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—urinary bladder cancer	9.94e-05	0.000306	CcSEcCtD
Fosphenytoin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	9.66e-05	0.00141	CbGpPWpGaD
Fosphenytoin—Asthenia—Methotrexate—urinary bladder cancer	9.64e-05	0.000297	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.58e-05	0.000295	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—urinary bladder cancer	9.5e-05	0.000292	CcSEcCtD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.4e-05	0.00137	CbGpPWpGaD
Fosphenytoin—Urticaria—Doxorubicin—urinary bladder cancer	9.24e-05	0.000284	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—urinary bladder cancer	9.19e-05	0.000283	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—urinary bladder cancer	9.19e-05	0.000283	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—urinary bladder cancer	9.02e-05	0.000278	CcSEcCtD
Fosphenytoin—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	9.02e-05	0.00132	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	9.01e-05	0.00132	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—RHOA—urinary bladder cancer	8.91e-05	0.0013	CbGpPWpGaD
Fosphenytoin—Pruritus—Epirubicin—urinary bladder cancer	8.89e-05	0.000274	CcSEcCtD
Fosphenytoin—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.89e-05	0.0013	CbGpPWpGaD
Fosphenytoin—Dizziness—Methotrexate—urinary bladder cancer	8.88e-05	0.000273	CcSEcCtD
Fosphenytoin—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	8.75e-05	0.00128	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.74e-05	0.00128	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	8.63e-05	0.00126	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.63e-05	0.00126	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Epirubicin—urinary bladder cancer	8.6e-05	0.000265	CcSEcCtD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.57e-05	0.00125	CbGpPWpGaD
Fosphenytoin—Vomiting—Methotrexate—urinary bladder cancer	8.54e-05	0.000263	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—urinary bladder cancer	8.47e-05	0.000261	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—urinary bladder cancer	8.46e-05	0.00026	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—urinary bladder cancer	8.41e-05	0.000259	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—urinary bladder cancer	8.34e-05	0.000257	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—urinary bladder cancer	8.31e-05	0.000256	CcSEcCtD
Fosphenytoin—SCN5A—Axon guidance—ERBB2—urinary bladder cancer	8.25e-05	0.00121	CbGpPWpGaD
Fosphenytoin—Pruritus—Doxorubicin—urinary bladder cancer	8.23e-05	0.000253	CcSEcCtD
Fosphenytoin—SCN5A—Developmental Biology—CDK4—urinary bladder cancer	8.06e-05	0.00118	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	8.04e-05	0.00118	CbGpPWpGaD
Fosphenytoin—Vomiting—Epirubicin—urinary bladder cancer	7.99e-05	0.000246	CcSEcCtD
Fosphenytoin—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	7.98e-05	0.00117	CbGpPWpGaD
Fosphenytoin—Nausea—Methotrexate—urinary bladder cancer	7.98e-05	0.000246	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—urinary bladder cancer	7.96e-05	0.000245	CcSEcCtD
Fosphenytoin—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.93e-05	0.00116	CbGpPWpGaD
Fosphenytoin—Rash—Epirubicin—urinary bladder cancer	7.93e-05	0.000244	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—urinary bladder cancer	7.92e-05	0.000244	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—urinary bladder cancer	7.87e-05	0.000242	CcSEcCtD
Fosphenytoin—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.87e-05	0.00115	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	7.83e-05	0.00114	CbGpPWpGaD
Fosphenytoin—Dizziness—Doxorubicin—urinary bladder cancer	7.69e-05	0.000237	CcSEcCtD
Fosphenytoin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	7.59e-05	0.00111	CbGpPWpGaD
Fosphenytoin—Nausea—Epirubicin—urinary bladder cancer	7.47e-05	0.00023	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—urinary bladder cancer	7.4e-05	0.000228	CcSEcCtD
Fosphenytoin—ALB—Folate Metabolism—TNF—urinary bladder cancer	7.34e-05	0.00107	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	7.33e-05	0.00107	CbGpPWpGaD
Fosphenytoin—Rash—Doxorubicin—urinary bladder cancer	7.33e-05	0.000226	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—urinary bladder cancer	7.33e-05	0.000226	CcSEcCtD
Fosphenytoin—SCN5A—Developmental Biology—PPARG—urinary bladder cancer	7.32e-05	0.00107	CbGpPWpGaD
Fosphenytoin—Headache—Doxorubicin—urinary bladder cancer	7.29e-05	0.000224	CcSEcCtD
Fosphenytoin—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.23e-05	0.00106	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.12e-05	0.00104	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	7.1e-05	0.00104	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—MMP9—urinary bladder cancer	7.08e-05	0.00103	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—CREBBP—urinary bladder cancer	7.03e-05	0.00103	CbGpPWpGaD
Fosphenytoin—Nausea—Doxorubicin—urinary bladder cancer	6.91e-05	0.000213	CcSEcCtD
Fosphenytoin—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	6.73e-05	0.000983	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NAT1—urinary bladder cancer	6.73e-05	0.000983	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—SRC—urinary bladder cancer	6.53e-05	0.000954	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—TP53—urinary bladder cancer	6.47e-05	0.000946	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	6.36e-05	0.00093	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	6.15e-05	0.000899	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	6.01e-05	0.000878	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTZ1—urinary bladder cancer	5.97e-05	0.000873	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	5.89e-05	0.000861	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	5.83e-05	0.000852	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—EGFR—urinary bladder cancer	5.72e-05	0.000836	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	5.69e-05	0.000832	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NAT1—urinary bladder cancer	5.69e-05	0.000832	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTO2—urinary bladder cancer	5.66e-05	0.000828	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NAT1—urinary bladder cancer	5.66e-05	0.000828	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.6e-05	0.000819	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.57e-05	0.000814	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	5.54e-05	0.00081	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—KRAS—urinary bladder cancer	5.4e-05	0.00079	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	5.36e-05	0.000784	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.26e-05	0.000769	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	5.23e-05	0.000765	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	5.21e-05	0.000761	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.19e-05	0.000759	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—UGT2B7—urinary bladder cancer	5.18e-05	0.000757	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	5.1e-05	0.000745	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.08e-05	0.000743	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.08e-05	0.000743	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	5.05e-05	0.000738	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5e-05	0.000731	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	4.98e-05	0.000729	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	4.89e-05	0.000715	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.84e-05	0.000707	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.81e-05	0.000704	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—EP300—urinary bladder cancer	4.79e-05	0.0007	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.77e-05	0.000697	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	4.69e-05	0.000685	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP4B1—urinary bladder cancer	4.66e-05	0.000682	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—SRC—urinary bladder cancer	4.66e-05	0.000681	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.65e-05	0.00068	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.63e-05	0.000677	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.63e-05	0.000677	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—HRAS—urinary bladder cancer	4.59e-05	0.000671	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	4.57e-05	0.000667	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.56e-05	0.000666	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IFNA2—urinary bladder cancer	4.44e-05	0.00065	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	4.43e-05	0.000647	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SLC19A1—urinary bladder cancer	4.4e-05	0.000644	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	4.32e-05	0.000631	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PRSS3—urinary bladder cancer	4.29e-05	0.000627	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.24e-05	0.00062	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.19e-05	0.000612	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	4.08e-05	0.000597	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.08e-05	0.000596	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.95e-05	0.000578	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TNF—urinary bladder cancer	3.89e-05	0.000568	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	3.86e-05	0.000564	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.85e-05	0.000563	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	3.83e-05	0.00056	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.82e-05	0.000558	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NAT2—urinary bladder cancer	3.69e-05	0.000539	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.6e-05	0.000527	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.51e-05	0.000513	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.46e-05	0.000506	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.45e-05	0.000504	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.44e-05	0.000503	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—TYMP—urinary bladder cancer	3.43e-05	0.000501	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	3.34e-05	0.000489	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.31e-05	0.000484	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.29e-05	0.000482	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	3.28e-05	0.000479	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.22e-05	0.000471	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.18e-05	0.000465	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PLAU—urinary bladder cancer	3.15e-05	0.000461	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NAT2—urinary bladder cancer	3.12e-05	0.000456	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NAT2—urinary bladder cancer	3.1e-05	0.000454	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.09e-05	0.000451	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.08e-05	0.00045	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.06e-05	0.000447	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.06e-05	0.000447	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.96e-05	0.000432	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.95e-05	0.000431	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.95e-05	0.000431	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.86e-05	0.000418	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.82e-05	0.000412	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.81e-05	0.00041	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.8e-05	0.000409	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.78e-05	0.000407	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.7e-05	0.000394	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.69e-05	0.000394	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—RRM2—urinary bladder cancer	2.68e-05	0.000391	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—CREBBP—urinary bladder cancer	2.6e-05	0.00038	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IGF1—urinary bladder cancer	2.57e-05	0.000376	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.54e-05	0.000371	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.52e-05	0.000368	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.49e-05	0.000365	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.49e-05	0.000365	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HPGDS—urinary bladder cancer	2.48e-05	0.000363	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ENO2—urinary bladder cancer	2.48e-05	0.000363	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.48e-05	0.000362	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.47e-05	0.00036	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.42e-05	0.000354	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTT1—urinary bladder cancer	2.41e-05	0.000352	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.4e-05	0.000351	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.38e-05	0.000348	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.38e-05	0.000347	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.37e-05	0.000347	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.37e-05	0.000346	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—RHOA—urinary bladder cancer	2.35e-05	0.000344	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.32e-05	0.000339	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.25e-05	0.000329	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.23e-05	0.000325	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.23e-05	0.000325	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.21e-05	0.000324	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.19e-05	0.00032	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.16e-05	0.000316	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.13e-05	0.000311	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.03e-05	0.000297	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.03e-05	0.000297	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.02e-05	0.000295	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.01e-05	0.000294	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NQO1—urinary bladder cancer	2e-05	0.000292	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.98e-05	0.00029	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—urinary bladder cancer	1.97e-05	0.000289	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.97e-05	0.000288	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.95e-05	0.000285	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.94e-05	0.000284	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.94e-05	0.000283	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.85e-05	0.000271	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.84e-05	0.000269	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.82e-05	0.000266	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.82e-05	0.000266	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.79e-05	0.000262	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—EP300—urinary bladder cancer	1.77e-05	0.000259	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.74e-05	0.000255	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.74e-05	0.000255	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SRC—urinary bladder cancer	1.72e-05	0.000252	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.71e-05	0.00025	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.7e-05	0.000249	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.69e-05	0.000247	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.68e-05	0.000245	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.67e-05	0.000245	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTP1—urinary bladder cancer	1.67e-05	0.000244	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.64e-05	0.000239	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.62e-05	0.000237	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.61e-05	0.000236	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.61e-05	0.000235	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.59e-05	0.000232	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.56e-05	0.000228	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—TYMS—urinary bladder cancer	1.55e-05	0.000227	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.54e-05	0.000225	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.54e-05	0.000225	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NCOR1—urinary bladder cancer	1.53e-05	0.000224	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTM1—urinary bladder cancer	1.53e-05	0.000224	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.52e-05	0.000222	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.5e-05	0.000219	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.48e-05	0.000216	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GPX1—urinary bladder cancer	1.47e-05	0.000214	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.45e-05	0.000212	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.45e-05	0.000212	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.45e-05	0.000211	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ERCC2—urinary bladder cancer	1.44e-05	0.000211	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—KRAS—urinary bladder cancer	1.43e-05	0.000209	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.39e-05	0.000203	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.38e-05	0.000202	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.38e-05	0.000201	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.38e-05	0.000201	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.36e-05	0.0002	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.36e-05	0.000199	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—MTHFR—urinary bladder cancer	1.35e-05	0.000198	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.34e-05	0.000196	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.34e-05	0.000196	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.32e-05	0.000193	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.32e-05	0.000193	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.3e-05	0.000191	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.3e-05	0.00019	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.29e-05	0.000189	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.27e-05	0.000185	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—urinary bladder cancer	1.27e-05	0.000185	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.25e-05	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	0.000178	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—HRAS—urinary bladder cancer	1.21e-05	0.000177	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.2e-05	0.000176	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000172	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	0.000162	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.1e-05	0.000161	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPARG—urinary bladder cancer	1.1e-05	0.000161	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.08e-05	0.000158	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.06e-05	0.000155	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CREBBP—urinary bladder cancer	1.05e-05	0.000154	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.03e-05	0.00015	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	9.86e-06	0.000144	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	9.47e-06	0.000138	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9e-06	0.000132	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	8.99e-06	0.000131	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	8.95e-06	0.000131	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	8.69e-06	0.000127	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTGS2—urinary bladder cancer	8.64e-06	0.000126	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	8.63e-06	0.000126	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—EP300—urinary bladder cancer	8.53e-06	0.000125	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.37e-06	0.000122	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.27e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.27e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.92e-06	0.000116	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.78e-06	0.000114	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	7.75e-06	0.000113	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	7.58e-06	0.000111	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTEN—urinary bladder cancer	7.53e-06	0.00011	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.31e-06	0.000107	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—EP300—urinary bladder cancer	7.23e-06	0.000106	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—EP300—urinary bladder cancer	7.18e-06	0.000105	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.07e-06	0.000103	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	6.76e-06	9.89e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—EP300—urinary bladder cancer	6.45e-06	9.43e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.17e-06	9.01e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.93e-06	8.67e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.88e-06	8.6e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.69e-06	8.32e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.66e-06	6.82e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.07e-06	5.94e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.88e-06	5.67e-05	CbGpPWpGaD
